Marina Viktorovna Krotenkova

Marina Viktorovna Krotenkova

Auto-generated profile, based on publicly available information

Marina Viktorovna Krotenkova

Russian Center of Neurology and Neurosciences, 125367 Moscow, Russia

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in Cortex
Verified
Journal Article
Closed access
ODOlga R. Dobrushina
Olga R. Dobrushina
GAGalina A. Arina
Galina A. Arina
LDLarisa Dobrynina
Larisa Dobrynina
ENEvgenia S. Novikova
Evgenia S. Novikova
MGMariia Gubanova
Mariia Gubanova
MKMarina V. Krotenkova
Marina V. Krotenkova

29 January 2020 in Psychophysiology
Verified
Journal Article
Closed access
PDF file
ODOlga R. Dobrushina
Olga R. Dobrushina
GAGalina A. Arina
Galina A. Arina
LDLarisa Dobrynina
Larisa Dobrynina
ASAnastasia D. Suslina
Anastasia D. Suslina
PSPolina O. Solodchik
Polina O. Solodchik
MKMarina V. Krotenkova
Marina V. Krotenkova

5 August 2018 in Brain Sciences
Verified
Journal Article
Open access
PDF file
SMSofya Nikolaevna Morozova
Sofya Nikolaevna Morozova
EKElena Kremneva
Elena Kremneva
DSDmitry Sergeev
Dmitry Sergeev
DSDmitry Sinitsyn
Dmitry Sinitsyn
LLLiudmila Legostaeva
Liudmila Legostaeva
MPMichael Piradov
Michael Piradov
Differential diagnosis of unresponsive wakefulness syndrome (UWS) and minimally conscious state (MCS) is one of the most challenging problems for specialists who deal with chronic disorders of consciousness (DOC). The aim of the current study was to develop a conventional MRI-based scale and to evaluate its role in distinguishing chronic disorders of consciousness (Disorders of Consciousness MRI-based Distinguishing Scale, DOC-MRIDS). Data were acquired from 30 patients with clinically diagnosed chronic disorders of consciousness. All patients underwent conventional MRI using a Siemens Verio 3.0 T scanner, which included T2 and T1 sequences for patient assessment. Diffuse cortical atrophy, ventricular enlargement, sulcal widening, leukoaraiosis, brainstem and/or thalamus degeneration, corpus callosum degeneration, and corpus callosum lesions were assessed according to DOC-MRIDS criteria, with a total score calculation. The ROC-analysis showed that a reasonable threshold DOC-MRIDS total score was 5.5, that is, patients with DOC-MRIDS total score of 6 and above were classified as UWS and 5 and below as MCS, with sensitivity of 82.4% and specificity of 92.3%. The novel structural MRI-based scale for the assessment of typical brain lesions in patients with chronic DOC is relatively easy to apply, and provides good specificity and sensitivity values for discrimination between UWS and MCS.

1 January 2022 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
LDLarisa Dobrynina
Larisa Dobrynina
ZGZukhra Gadzhieva
Zukhra Gadzhieva
KSKamila V. Shamtieva
Kamila V. Shamtieva
EKElena Kremneva
Elena Kremneva
AFA.S. Filatov
A.S. Filatov
MKM.V. Krotenkova
M.V. Krotenkova
To search for sensitive predictors of cognitive impairment (CI) and an integrative index of their severity. We assessed CI and diffusion-tensor MRI (DT-MRI) in the regions of interest (ROI) significant for CI in 74 patients (48 women, mean age 60.6±6.9 years) with cerebral small vessel disease (CSVD). The results of DT-MRI were used to construct a predictive model of CI using binary logistic regression and to calculate an integrative index of CI severity. According to the constructed model, the predictors of CI were axial diffusivity (AD) of posterior frontal periventricular normal-appearing white matter (pvNAWM), right middle cingulum bundle (CB) and mid-posterior corpus callosum (CC). ROC analysis showed strong model predictive power for CI in cSVD (AUC (95% CI): 0.845 (0.740-0.950)). The threshold value of the AD predictors model for CI in cSVD was 0.53 (sensitivity 84%, specificity 76%). AD predictors of CI showed significant correlations with white matter hyperintensities volume and MoCA scores. The presence of CI as measured by neuropsychological testing and regression equation solution was corresponded to individual AD predictors of patients exceeding the CI model's threshold. Disturbances in the AD of pvNAWM, right middle CB and mid-posterior CC associated with axonal damage are a predominant factor in the development of CI in CSVD. The predictors of CI and the integrative index of CI severity calculated on their basis can potentially be used as a tool for assessing the severity of CI and the effectiveness of treatment, as well as in clarifying the interaction between vascular and degenerative pathology and in developing measures for the prevention of CI in patients with MRI signs of cSVD.

29 May 2020 in Diagnostics
Verified
Journal Article
Open access
PDF file
LDLarisa Dobrynina
Larisa Dobrynina
MZMaryam Zabitova
Maryam Zabitova
ASAlla A. Shabalina
Alla A. Shabalina
EKElena Kremneva
Elena Kremneva
BABulat M. Akhmetzyanov
Bulat M. Akhmetzyanov
MKMarina V. Krotenkova
Marina V. Krotenkova
The evaluation of the clustering of magnetic resonance imaging (MRI) signs into MRI types and their relationship with circulating markers of vascular wall damage were performed in 96 patients with cerebral small vessel disease (cSVD) (31 men and 65 women; mean age, 60.91 ± 6.57 years). The serum concentrations of the tumor necrosis factor-α (TNF-α), transforming growth factor-β1 (TGF-β1), vascular endothelial growth factor-A (VEGF-A), and hypoxia-inducible factor 1-α (HIF-1α) were investigated in 70 patients with Fazekas stages 2 and 3 of white matter hyperintensities (WMH) and 21 age- and sex-matched volunteers with normal brain MRI using ELISA. The cluster analysis excluded two patients from the further analysis due to restrictions in their scanning protocol. MRI signs of 94 patients were distributed into two clusters. In the first group there were 18 patients with Fazekas 3 stage WMH. The second group consisted of 76 patients with WMH of different stages. The uneven distribution of patients between clusters limited the subsequent steps of statistical analysis; therefore, a cluster comparison was performed in patients with Fazekas stage 3 WMH, designated as MRI type 1 and type 2 of Fazekas 3 stage. There were no differences in age, sex, degree of hypertension, or other risk factors. MRI type 1 had significantly more widespread WMH, lacunes in many areas, microbleeds, atrophy, severe cognitive and gait impairments, and was associated with downregulation of VEGF-A compared with MRI type 2. MRI type 2 had more severe deep WMH, lacunes in the white matter, no microbleeds or atrophy, and less severe clinical manifestations and was associated with upregulation of TNF-α compared with MRI type 1. The established differences reflect the pathogenetic heterogeneity of cSVD and explain the variations in the clinical manifestations observed in Fazekas stage 3 of this disease.

19 September 2020 in Diagnostics
Verified
Journal Article
Open access
PDF file
LDLarisa Dobrynina
Larisa Dobrynina
ZGZukhra Gadzhieva
Zukhra Gadzhieva
KSKamila V. Shamtieva
Kamila V. Shamtieva
EKElena Kremneva
Elena Kremneva
BABulat M. Akhmetzyanov
Bulat M. Akhmetzyanov
MKMarina V. Krotenkova
Marina V. Krotenkova
Introduction: Cerebral small vessel disease (CSVD) is the leading cause of vascular and mixed degenerative cognitive impairment (CI). The variability in the rate of progression of CSVD justifies the search for sensitive predictors of CI. Materials: A total of 74 patients (48 women, average age 60.6 ± 6.9 years) with CSVD and CI of varying severity were examined using 3T MRI. The results of diffusion tensor imaging with a region of interest (ROI) analysis were used to construct a predictive model of CI using binary logistic regression, while phase-contrast magnetic resonance imaging and voxel-based morphometry were used to clarify the conditions for the formation of CI predictors. Results: According to the constructed model, the predictors of CI are axial diffusivity (AD) of the posterior frontal periventricular normal-appearing white matter (pvNAWM), right middle cingulum bundle (CB), and mid-posterior corpus callosum (CC). These predictors showed a significant correlation with the volume of white matter hyperintensity; arterial and venous blood flow, pulsatility index, and aqueduct cerebrospinal fluid (CSF) flow; and surface area of the aqueduct, volume of the lateral ventricles and CSF, and gray matter volume. Conclusion: Disturbances in the AD of pvNAWM, CB, and CC, associated with axonal damage, are a predominant factor in the development of CI in CSVD. The relationship between AD predictors and both blood flow and CSF flow indicates a disturbance in their relationship, while their location near the floor of the lateral ventricle and their link with indicators of internal atrophy, CSF volume, and aqueduct CSF flow suggest the importance of transependymal CSF transudation when these regions are damaged.